Inside Big Insurance’s $1.7 Trillion Year | EP 2

The seven for‑profit insurers that dominate America’s health market generated a staggering $1.7 trillion in revenue and $54 billion in profit in 2025—outpacing Apple, ExxonMobil and many Fortune‑500 giants. Their growth is not driven by more members; enrollment fell by ten million, yet revenues surged thanks to aggressive acquisitions, expansion into pharmacy benefit management, and deepening ties to Medicare Advantage and Medicaid. Companies like UnitedHealth, CVS/Aetna, Cigna’s Evernorth, and Centene now pull the majority of their earnings from taxpayer‑funded programs, reshaping the industry into a quasi‑government contractor.

The earnings reports released this year are massive, jargon‑heavy documents that mask how little of premium dollars actually reach patient care. Medical loss ratios—now often rebranded as “medical care ratios”—hover around 80‑85%, leaving the balance for executive compensation, advertising and high administrative overhead. To please Wall Street, insurers have bought back roughly $140 billion of their own stock over the past decade, artificially boosting earnings per share while keeping premiums high. Meanwhile, churn tactics such as “purging” costly enrollees and shifting markets have reduced coverage for millions, especially as subsidies disappear.

Understanding these filings is essential for journalists, policymakers and consumers alike. By dissecting the numbers—comparing decade‑long trends, isolating public‑program revenue, and exposing stock‑buyback strategies—stakeholders can reveal how the industry extracts value from taxpayers while delivering minimal health outcomes. Transparent analysis empowers advocates to demand reforms, protect patients from escalating costs, and hold insurers accountable for the true price of America’s biggest private‑sector health providers.